These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 437452)

  • 61. Blood donors with a history of jaundice.
    Jones PM
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):834. PubMed ID: 6811032
    [No Abstract]   [Full Text] [Related]  

  • 62. Failure of hyperimmune serum globulin, given several days after exposure, to protect against hepatitis B.
    Frösner GG; Frösner HR; Dienhardt F; Haussman W; Knabe UH
    Lancet; 1977 Nov; 2(8046):1023. PubMed ID: 72913
    [No Abstract]   [Full Text] [Related]  

  • 63. Hazardous donors.
    Shafer AW
    JAMA; 1978 Jun; 239(23):2446-7. PubMed ID: 650817
    [No Abstract]   [Full Text] [Related]  

  • 64. Immune hepatitis B plasma procurement.
    Leen CL; Wilson R; Yap PL; McClelland DB
    Vox Sang; 1985; 49(5):323-6. PubMed ID: 4082529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delayed hepatitis after treatment with hepatitis B immune serum globulin.
    Wauters JP; Leski M
    Br Med J; 1976 Jul; 2(6026):19-20. PubMed ID: 938878
    [No Abstract]   [Full Text] [Related]  

  • 66. Hepatitis B carriers in the classroom.
    Krugman S
    JAMA; 1985 Dec; 254(22):3218-9. PubMed ID: 4068157
    [No Abstract]   [Full Text] [Related]  

  • 67. Priorities for immunisation against hepatitis B.
    O'Connor J
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1876. PubMed ID: 6805745
    [No Abstract]   [Full Text] [Related]  

  • 68. On stimulating the gift of blood.
    Bevan W
    Science; 1971 Aug; 173(3997):583. PubMed ID: 5564592
    [No Abstract]   [Full Text] [Related]  

  • 69. Editorial: Labeling human blood: an ominous sign?
    Sampson CC
    J Natl Med Assoc; 1976 May; 68(3):235-6. PubMed ID: 933198
    [No Abstract]   [Full Text] [Related]  

  • 70. [Hepatitis B].
    Aramaki T
    Nihon Ika Daigaku Zasshi; 1986 Dec; 53(6):605-8. PubMed ID: 3805243
    [No Abstract]   [Full Text] [Related]  

  • 71. A large-scale preparation of human albumin for use in metabolic studies in man.
    Vallet L
    Bibl Haematol; 1965; 23():1191-2. PubMed ID: 5885203
    [No Abstract]   [Full Text] [Related]  

  • 72. [Methods for the detection and prevention of post-transfusion hepatitis].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):591-5. PubMed ID: 7247675
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevention of type B hepatitis.
    Hoofnagle JH
    Gastroenterology; 1979 Jun; 76(6):183-5. PubMed ID: 437452
    [No Abstract]   [Full Text] [Related]  

  • 74. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 75. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 76. [The epidemiology, clinical picture and prevention of viral hepatitis B].
    Bondarenlo IA
    Feldsher Akush; 1990 Dec; 55(12):8-12. PubMed ID: 2090503
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.